The Biotechnology Sector: "Bounds" to Market Structure
| dc.creator | Sheldon, Ian M. | |
| dc.date | 2017-04-01T19:42:47Z | |
| dc.date.accessioned | 2026-07-09T02:46:44Z | |
| dc.description | This paper examines whether it makes sense to consider Sutton's "bounds" approach as a candidate theory for explaining the recent evolution of market structure in the biotechnology sector, and to speculate whether market structure will change if the industry begins to introduce second-generation GM products that are of more direct benefit to consumers. A key result is that the market structure is bounded in the presence of endogenous sunk costs, implying care should be taken when inferring any correlation between R&D expenditure and seller concentration in the biotechnology sector. | |
| dc.identifier | doi:10.22004/ag.econ.6078 | |
| dc.identifier | https://ageconsearch.umn.edu/record/6078/files/470031.pdf | |
| dc.identifier | http://ageconsearch.umn.edu/record/6078 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/519839 | |
| dc.language | eng | |
| dc.publisher | ||
| dc.source | http://ageconsearch.umn.edu/record/6078 | |
| dc.title | The Biotechnology Sector: "Bounds" to Market Structure | |
| dc.type | Text |